Friday, June 19, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1054 of 1,261

  1. US 7410776

    Polypeptides, their production and use

    Takeda Pharmaceutical Company Limited · Granted Aug 12, 2008 · Expires Aug 7, 2028

    granted

  2. US 7407664

    Peptide vaccines against group A streptococci

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Aug 5, 2008 · Expires Jul 31, 2028

    granted

  3. US 7408075

    Synthesis of phosphocholine ester derivatives and conjugates thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 5, 2008 · Expires Jul 31, 2028

    granted

  4. US 7407962

    Heteroaryl compounds useful as inhibitors or protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 5, 2008 · Expires Jul 31, 2028

    granted

  5. US 7407658

    Vaccines for blocking transmission of plasmodium vivax

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 5, 2008 · Expires Jul 31, 2028

    granted

  6. US 7407964

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 5, 2008 · Expires Jul 31, 2028

    granted

  7. US 7407939

    Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics

    CureGenics Ltd. · Granted Aug 5, 2008 · Expires Jul 31, 2028

    granted

  8. US 7407935

    Ricin toxin A-chain fragment for use as a vaccine

    The United States of America as represented by the Secretary of the Army · Granted Aug 5, 2008 · Expires Jul 31, 2028

    granted

  9. US 7407976

    Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Aug 5, 2008 · Expires Jul 31, 2028

    granted

  10. US 7407656

    PSCA: prostate stem cell antigen and uses thereof

    The Regents of the University of California · Granted Aug 5, 2008 · Expires Jul 31, 2028

    granted

  11. US 7405041

    Methods for regulating transcription by targeting quadruplex DNA

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  12. US 7405202

    CRISP polypeptides as contraceptives and inhibitors of sperm capacitation

    Regents of the University of Minnesota · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  13. US 7405302

    5-lipoxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  14. US 7405266

    Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof

    Nektar Therapeutics AL, Corporation · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  15. US 7405199

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  16. US 7405233

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  17. US 7405314

    Compounds and methods for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  18. US 7405287

    Method of treating a cancer

    The Board of Regents of the University of Texas System · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  19. US 7404956

    Immunoglobulin chimeric monomer-dimer hybrids

    Syntonix Pharmaceuticals, Inc. · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  20. US 7404961

    Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins

    The United States of America as represented by the Secretary of the Army · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  21. US 7405286

    Stars—A muscle-specific actin-binding protein

    The Board of Regents of the University of Texas System · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  22. US 7404954

    Methods of targeting agents to cells expressing the polymeric immunoglobulin receptor

    The Regents of the University of California · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted

  23. US 7402590

    Spiroazacyclic compounds as monoamine receptor modulators

    ACADIA Pharmaceuticals Inc. · Granted Jul 22, 2008 · Expires Jul 17, 2028

    granted

  24. US 7402659

    Thymic stromal lymphopoietin receptor molecules and uses thereof

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA · Granted Jul 22, 2008 · Expires Jul 17, 2028

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.